Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 9 (4) , 301-308
- https://doi.org/10.1016/0165-1781(83)90003-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Dopamine-β-Hydroxylase Activity and Homovanillic Acid in Spinal Fluid of Schizophrenics with Brain AtrophyScience, 1983
- Computed tomography of the brain in patients with acute psychosis and in healthy volunteersActa Psychiatrica Scandinavica, 1982
- Cortical and central atrophy in chronic schizophreniaActa Psychiatrica Scandinavica, 1982
- Differentiation of Chronic Schizophrenics With and Without Ventricular Enlargement By of Lurai-Nebraska Neuropsychological BatteryInternational Journal of Neuroscience, 1980
- CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIAPublished by Elsevier ,1976
- Acid Metabolites from Monoamines in Cerebrospinal Fluid of Chronic SchizophrenicsThe British Journal of Psychiatry, 1969
- 5-HYDROXYINDOLE COMPOUNDS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH PSYCHIATRIC OR NEUROLOGICAL DISEASESThe Lancet, 1966
- Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatumLife Sciences, 1964
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963
- Encephalographische Studien an chronisch SchizophrenenArchiv Fur Psychiatrie Und Nervenkrankheiten, 1927